CTEG: How can you predict if your discovery is translatable?

A presentation by David Kaplan, PhD (SickKids Research Institute) at the Bench to Bedside for Biotherapeutics (B3) Workshop held in Toronto on October 5, 2017.

In this seminar, Dr. Kaplan shares lessons learned through translating basic research findings into commercial products and clinical trials. Dr. Kaplan highlights his experience in developing two companies from work generated in his lab as well a meeting with key stakeholder to develop guidelines and set a “bar” to determine when their basic lab research was ready to move forward into a clinical trial.

This video is presented by the Clinical Translation Education Group:  BioCanRx, CCRM, CellCAN, Foundation Fighting Blindness, Ontario Institute for Cancer Research, Ontario Institute for Regenerative Medicine and Stem Cell Network.

All other pages contact

For more information, please contact us.

Subscribe to our mailing list to receive CCRM’s monthly newsletter.


You have Successfully Subscribed!